Biotech China 2014

Peptides: Merck

Total Score People Score Events Score
15 13 11
Date Event Presentation Speakers
June 23, 2010 Structure-Based Drug Design TABLE 4: Do We Get the Most Out of the Structural information in the PDB? Tips and Lessons Learned José Duca
Chairperson’s Remarks José Duca
April 30, 2010 Drug Story Dll4 and Notch1 Antagonist Antibodies Inhibit Yan Wu
October 6, 2009 Phage Display to Develop Therapeutic Antibodies Strategies for a Competitive Biologics Portfolio Georg Feger
July 20, 2008 WORLD SUMMIT OF ANTIVIRALS Combating Severe Viral Infections Session 6: Omics and System Biology for Viral Infectious Diseases Xiaohua Douglas Zhang
Analytic Methods in Genome-Scale RNAi Research with Applications in Drug Discovery for Viral Infectious Diseases Xiaohua Douglas Zhang
April 27, 2008 Phage Display of Antibodies and Peptides Dll4 and Notch1 Antagonist Antibodies Inhibit Tumor Growth by Deregulating Angiogenesis Yan Wu
April 27, 2008 Phage Display of Antibodies and Peptides Dll4 and Notch1 Antagonist Antibodies Inhibit Tumor Growth by Deregulating Angiogenesis Yan Wu
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Ligands for Melanocortin Receptors Maria Bednarek
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Assessing Structure/Function Relationships (08:15-10:45) Michael W. Washabaugh
Assessing Structure/Function Relationships :Assessing Product Potency & Related Characteristics of Gardasil,® a Recombinant HPV Vaccine (09:45-10:15) Michael W. Washabaugh
CMC Approaches to Specific and Emerging Biotech Products (09:15-10:45) David Wohlpart
CMC Approaches to Specific and Emerging Biotech Products: Characterization of Synthetic Peptides for Biotechnology - Unique Challenges (09:45-10:15) David Wohlpart
Impact of Extractables and Leachables on Well Characterized Protein Products (10:45-13:25) John P. Hennessey
Emerging Analytical Technologies (13:25-15:30) John P. Hennessey
Emerging Analytical Technologies: Chairperson's Remarks (13:25-13:30) John P. Hennessey
Process and Analytical Related Issues: Specifications - The Interface between Clinical, Analytical, and Process (16:00-16:30) Timothy , Schofield
Process and Analytical Related Issues (15:30-17:00) Timothy , Schofield
November 7, 2007 Antibodies Europe: Engineering the Next Generation of Antibodies Nov (07-08) Engineering for Optimum Performance and Yield (16:15-19:15) Ping Zhong
Engineering for Optimum Performance and Yield: Antibody Optimization by AISIM Technology (17:45-18:15) Ping Zhong
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 1: Keynote Forum (09:30 -12:00) Dr. Bharatt M. Chowrira
Session 1: Embracing Cross-Border Alliances to Expand and Advance Drug Discovery Activities (10:00-10:30) Dr. Bharatt M. Chowrira
Session 4: (Part One) Anti-Infectious Drug Discovery & Development (I) (Part Two) RNAi & Gene: Applications in Drug Discovery and Therapeutics (13:30-17:05) Dr. Bharatt M. Chowrira
Session 4: RNAi-Based Therapeutics- The Promise and Challenges (15:00-15:20) Dr. Bharatt M. Chowrira
Session 9: Innovative Metabolic Diseases Drug Discovery & Development (13:30-17:05) Ruojing Yang
Session 9: RNA Interference for Target Identification and Validation (13:30-13:50) Ruojing Yang
September 24, 2007 12th Annual Drug Delivery Technologies & Deal Making Track B: Partnering at Merck to Facilitate Delivery Challenges Kimberly Folander
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.